Doxobid is an antitussive indicated for asthma and Chronic Obstructive Pulmonary Disease (COPD).
Inhibition of phosphodiesterase which converts cAMP to AMP.
Plasma protein binding is 48%. Renal Excretion accounts for less than 4% and plasma half life is 7.42 hours.
Adult: 400 mg once a day. Single dose administration in the evening reduces nocturnal symptoms and helps to keep the patients complaint free during the day. However, in certain cases 400 mg twice daily is recommended on the basis of the clinical response.
Available in 400mg tablet Each strip contains 10 tablets.